These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 34503427)

  • 41. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol).
    Tavassoli N; Lapeyre-Mestre M; Sommet A; Montastruc JL;
    Br J Clin Pharmacol; 2009 Sep; 68(3):422-6. PubMed ID: 19740400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Life-threatening drug reactions in children].
    Leśniak M; Woron J; Czarnobilska E
    Przegl Lek; 2013; 70(12):1003-7. PubMed ID: 24720116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
    Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ibuprofen-associated hypothermia in children: analysis of the Italian spontaneous reporting database.
    Donati M; Monaco L; Melis M; Sottosanti L; Biagi C; Vaccheri A; Motola D
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1239-1243. PubMed ID: 27417946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010-2019.
    Montastruc JL
    Br J Clin Pharmacol; 2023 Jan; 89(1):201-208. PubMed ID: 35881623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
    Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
    Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
    Wallerstedt SM; Brunlöf G; Sundström A
    Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric adverse reactions to antiseizure medications - An analysis of data from the Italian spontaneous reporting system (2001-2019).
    Franco V; Barbieri MA; Cutroneo PM; Arena I; Cicala G; Marchione P; Spina E; Perucca E
    Epilepsy Behav; 2021 Jun; 119():107989. PubMed ID: 33946010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.
    Taugourdeau-Raymond S; Rouby F; Default A; Jean-Pastor MJ;
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1103-7. PubMed ID: 22349162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
    van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
    Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse drugs reactions to paracetamol and ibuprofen in children: a 5-year report from a pediatric poison control center in Italy.
    Marano M; Roversi M; Severini F; Memoli C; Musolino A; Pisani M; Cecchetti C; Villani A
    Ital J Pediatr; 2023 Feb; 49(1):20. PubMed ID: 36788576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication.
    Gras M; Gras-Champel V; Moragny J; Delaunay P; Laugier D; Masmoudi K; Liabeuf S
    Ann Pharm Fr; 2021 Sep; 79(5):522-529. PubMed ID: 33631179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Active Pharmacovigilance Project on the safety profile of Dolutegravir in Brazil.
    Mendes JC; Ceccato MDGB; Reis AMM; Costa AMGD; Pantuzza LLN; Furtado Dos Santos S; Crepalde-Ribeiro K; Silveira MR
    AIDS Care; 2023 May; 35(5):729-738. PubMed ID: 35578399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.